ArticleThe Journal of clinical endocrinology and metabolism2016

Response to the Letter: Bone Turnover as a Potential Determinant of Bone Mineral Density Increase Following the Transition From Bisphosphonates to Either Denosumab or Zoledronic Acid.

Paul D Miller et al.PubMed ↗Publisher ↗

No numbers read from the abstract.